5-AR inhibitor reduces risk of BPH-associated events


Chicago-Real-world clinical practice data provide further evidencethat treatment with a 5-alpha-reductase inhibitor significantly reducesthe risks for progression to acute urinary retention (AUR), catheterization,or surgery in men with BPH, according to a retrospective analysis from theUnited Kingdom.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.